Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Kodak Launches New Imaging Agent Product Line for Research Applications

Abstract:
Eastman Kodak Company's Molecular Imaging Systems group announced the introduction of KODAK X-SIGHT Imaging Agents, a novel line of imaging agents for in vivo molecular imaging applications.

Kodak Launches New Imaging Agent Product Line for Research Applications

NEW HAVEN, CT | Posted on February 13th, 2007

Once attached to a molecule and injected into an organism, the X-SIGHT imaging agents will travel to the target ( such as a tumor or plaque ) and illuminate the region of interest when excited by the appropriate wavelength of fluorescent light. X-SIGHT imaging agents are biocompatible and non-cytotoxic, making them safe and translatable for research studies in areas such as oncology, cardiology, diabetes, and inflammation, to name a few. They deliver not only superior brightness, but also enhanced photostability allowing more time for image capture.

This new product line leverages Kodak's 50 years of dye chemistry and nanotechnology expertise, merging world-class dyes with a state-of-the-art nanoparticle construct. X-SIGHT imaging agents are uniquely designed to offer biocompatibility along with superior brightness, providing researchers an incredibly bright and robust platform for safely locating their target of interest in vivo.

Together with Kodak's In-Vivo Imaging Systems, the X-SIGHT Imaging Agent line further expands the breadth of leading-edge solutions offered from Kodak to the research community.

"The launch of X-SIGHT Imaging Agents, is a significant milestone toward offering our customers a complete solution of systems and agents to advance their research," commented Shahram Hejazi, PhD, General Manager of Kodak's Molecular Imaging Systems division. "This introduction strengthens our leadership in the molecular imaging arena as we move forward to bridge the gap between preclinical and clinical applications."

X-SIGHT imaging agents can be readily conjugated to a wide range of targeting molecules, including peptides and antibodies, and their proprietary design can accommodate higher payloads of such targets while allowing for longer circulation time. Furthermore, X-SIGHT imaging agents are available in several distinct fluorescent wavelengths, enabling multi-fluorescent in vivo imaging. While the X-SIGHT imaging agents have been optimized for Kodak's In-Vivo Imaging Systems, they are also compatible with other commercially available systems.

X-SIGHT imaging agents are currently available for preclinical use in the United States and will be launched worldwide in March. Kodak further plans to introduce additional imaging agents throughout the year.

####

About Kodak’s Molecular Imaging Systems Group
Eastman Kodak Company’s Molecular Imaging Systems group - part of Kodak’s Health Group - develops and markets high performance digital imaging systems, imaging agents, film and accessories for the life science research and drug discovery/development market segments.

For more information, please click here

Contacts:
1-877-747-4357, express code 7.
Outside of the United States, call +1-203-786-5657.

Copyright © Eastman Kodak Company

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Products

PEN Inc. Announces Strategy to Broaden Clarity Branded Products Business February 4th, 2016

Graphenea increases capacity, reduces prices January 25th, 2016

Corrosion-Fighter Tesla NanoCoatings Pioneers 2x1 Wet-on-Wet Process January 20th, 2016

Iranian Company Mass-Produces Self-Cleaning Nanopaints November 14th, 2015

Nanomedicine

Leading bugs to the death chamber: A kinder face of cholesterol February 8th, 2016

UTHealth research looks at nanotechnology to help prevent preterm birth February 7th, 2016

Scientists take key step toward custom-made nanoscale chemical factories: Berkeley Lab researchers part of team that creates new function in tiny protein shell structures February 6th, 2016

Hepatitis virus-like particles as potential cancer treatment February 5th, 2016

Announcements

Scientists create laser-activated superconductor February 8th, 2016

Canadian physicists discover new properties of superconductivity February 8th, 2016

Leading bugs to the death chamber: A kinder face of cholesterol February 8th, 2016

From allergens to anodes: Pollen derived battery electrodes February 8th, 2016

Human Interest/Art

Rice to enter first international nanocar race: Five teams will participate in October 2016 event in France December 15th, 2015

Bionic liver micro-organs explain off-target toxicity of acetaminophen (Tylenol): Israeli-German partnership aims to replace animal experiments with advanced liver-on-chip devices August 17th, 2015

Omni Nano and Time Warner Cable Partner to Provide Nanotechnology Education to the Boys & Girls Clubs of Los Angeles: A $10,000 Donation to Benefit Youth of Los Angeles County's Boys & Girls Clubs August 4th, 2015

Kalam: versatility personified August 1st, 2015

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic